๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for GLP - 1

Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) Agonist Prior to Anesthesia NCT06654219NA1 site๐Ÿ“ Houston The University of Texas Health Science Center, Houston ยท Tests: GLP-1 RA users with prolonged fasting instructions, GLP-1 RA users with standard NPO instructions Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity NCT07091500NA1 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Exercise training, Semaglutide, Therapy Cessation Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes NCT05822609Phase 24 sites๐Ÿ“ Aurora๐Ÿ“ Seattle๐Ÿ“ Spokane University of Washington ยท Tests: Semaglutide, Placebo Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes NCT07210684NA1 site๐Ÿ“ Addison Nanjing Nutrabuilding Bio-tech Co., Ltd. ยท Tests: Placebo 400 mg, Dihydroberberine๏ผˆDHB๏ผ‰400 mg Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients NCT06774079Phase 41 site๐Ÿ“ Miami University of Miami ยท Tests: Tirzepatide, Mediterranean diet A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2) NCT07101939Phase 27 sites๐Ÿ“ Belgrade๐Ÿ“ Belgrade๐Ÿ“ Belgrade Actimed Therapeutics Ltd ยท Tests: (S)-pindolol benzoate, Semaglutide, Placebo to (S)-pindolol benzoate Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy NCT06903923Phase 21 site๐Ÿ“ Charlottesville University of Virginia ยท Tests: GLP-1 receptor agonist, Lifestyle intervention Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes NCT06706284Phase 42 sites๐Ÿ“ San Antonio๐Ÿ“ San Antonio Marzieh Salehi ยท Tests: Semaglutide Injectable Product, Placebo A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity NCT07243171Phase 1, Phase 21 site๐Ÿ“ Beijing Hangzhou Sciwind Biosciences Co., Ltd. ยท Tests: ecnoglutide tablets, placebo with matching dosage A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus NCT07082114Phase 31 site๐Ÿ“ Yueyang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. ยท Tests: HDM1002 100 mg, HDM1002 200 mg, HDM1002 400 mg, Dapagliflozin (DAPA) Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis NCT07497399Phase 22 sites๐Ÿ“ Baltimore๐Ÿ“ New York Johns Hopkins University ยท Tests: NLY01, Placebo Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder NCT07213466Phase 41 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Group Therapy Program, semaglutide, Phentermine-Topiramate, naltrexone and bupropion (combination) The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect NCT06058585Phase 351 sites๐Ÿ“ Garran๐Ÿ“ Kingswood๐Ÿ“ Kogarah The George Institute ยท Tests: Finerenone, Placebo Finerenone, Semaglutide, Placebo semaglutide Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists NCT07803185n/a1 site๐Ÿ“ Kayseri TC Erciyes University Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass NCT01803451EARLY Phase 12 sites๐Ÿ“ San Antonio๐Ÿ“ San Antonio The University of Texas Health Science Center at San Antonio ยท Tests: exendin-(9-39), exendin -(9-39) Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis NCT07017270Phase 42 sites๐Ÿ“ Toronto๐Ÿ“ Toronto Unity Health Toronto ยท Tests: Semaglutide Pen Bariatric Surgery Combined With GLP-1 Receptor Agonists Study NCT07336862Phase 1, Phase 21 site๐Ÿ“ Beijing China-Japan Friendship Hospital ยท Tests: BS-GLP group, BS group Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity NCT07136714Phase 41 site๐Ÿ“ Hillerรธd Nordsjaellands Hospital ยท Tests: Semaglutide Injectable Product, Placebo Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder NCT07523633Phase 21 site๐Ÿ“ Frederiksberg Anders Fink-Jensen, MD, DMSci ยท Tests: semaglutide, Placebo Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS) NCT07169136n/a1 site๐Ÿ“ Jacksonville Nemours Children's Clinic ยท Tests: GLP-1 Receptor Agonists A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs NCT05663515n/a8 sites๐Ÿ“ Copenhagen๐Ÿ“ Helsinki๐Ÿ“ Paris AstraZeneca ยท Tests: Exenatide, Non-GLP-1 RA based glucose lowering drugs Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease NCT06725693n/a3 sites๐Ÿ“ Hefei๐Ÿ“ Qingdao๐Ÿ“ Tianjin Tianjin Medical University ยท Tests: 18F/68Ga-Exendin 4 Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment NCT06069622n/a1 site๐Ÿ“ Boston Brigham and Women's Hospital ยท Tests: 24-hour ambulatory blood pressure, Liberal salt diet MAINTAIN (Mucosal AblatIoN Therapy After INcretins) NCT06734312NA2 sites๐Ÿ“ Cary๐Ÿ“ Cary Dr. Christopher McGowan ยท Tests: Gastric Fundal Mucosal Ablation (GFMA) Lifestyle Change Implementation Research Network at PRC at UMass Chan NCT07481305NA1 site๐Ÿ“ Worcester University of Massachusetts, Worcester ยท Tests: Digital Lifestyle Coaching Program People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists NCT07207148n/a1 site๐Ÿ“ Chicago Northwestern University ยท Tests: GLP-1, Ocrelizumab (US) Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes NCT06825182Phase 31 site๐Ÿ“ Nanjing Nanjing First Hospital, Nanjing Medical University ยท Tests: Outpatient newly diagnosed type 2 diabetes subjects, Inpatient newly diagnosed type 2 diabetes subjects Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation NCT07387796NA1 site๐Ÿ“ Dallas The University of Texas at Dallas ยท Tests: Discontinuation and Reinitiation of Tirzepatide A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight NCT07628127Phase 13 sites๐Ÿ“ Brisbane๐Ÿ“ Melbourne๐Ÿ“ Melbourne Verdiva Bio Dev Limited ยท Tests: VRB-103, Placebo, VRB-101 Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis NCT07282041Phase 2, Phase 31 site๐Ÿ“ Singapore National University of Singapore ยท Tests: Dulaglutide
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy